HOME >> BIOLOGY >> NEWS
Isoprene emission from plants -- a volatile answer to heat stress

Isoprene is a hydrocarbon volatile compound emitted in high quantities by many woody plant species, with significant impact on atmospheric chemistry. The Australian Blue Mountains and the Blue Ridge Mountains in the Eastern United States are so called because of the spectral properties of the huge amounts of isoprenes emitted from the trees growing there. Although a positive correlation has been observed between leaf temperature and isoprene emission in plants, the physiological role of isoprene emission, which is clearly quite costly to the plant, is still under vigorous debate.

One of the most popular hypotheses suggests that isoprene protects the metabolic processes in the leaf, in particular photosynthesis (the process by which plants use light energy to fix CO2 and produce their own food), against thermal stress. To test this hypothesis, scientists Katja Behnke and Jrg-Peter Schnitzler from the Institute for Meteorology and Climate Research of the Research Centre Karlsruhe in Garmisch-Partenkirchen in Germany, together with colleagues from the Universities of Braunschweig and Gttingen, also in Germany, and British Columbia, in Canada, recently applied genetic engineering techniques to obtain transgenic Grey poplar (Populus x canescens) trees with decreased isoprene emission, and examined their tolerance to heat. Their findings have been published in The Plant Journal.

Behnke et al. engineered such poplar trees by suppressing the expression of the gene encoding isoprene synthase (ISPS), the enzyme producing isoprene, by RNA interference (RNAi). They then subjected these trees to transient heat phases of 38-42C, each followed by phases of recovery at 30C, and measured the performance of photosynthesis. In these experiments, Behnke et al. observed that photosynthesis in trees that no longer emitted isoprenes was much less efficient under such repeated heat shocks (a situation that is similar to what happens in nature, where temperatures around
'"/>

Contact: Davina Quarterman
davina.quarterman@oxon.blackwellpublishing.com
01-865-476-307
Blackwell Publishing Ltd.
26-Jul-2007


Page: 1 2

Related biology news :

1. Climate change and permafrost thaw alter greenhouse gas emissions in northern wetlands
2. Particle emissions from laser printers might pose health concern
3. New multiple myeloma treatment induced total remission in 33 percent of patients
4. Blood test may help signal tumors remission, return in throat cancer patients
5. Alarming acceleration in CO2 emissions worldwide
6. Carnegie Mellon researchers urge regulators to rethink strategies for soot emission
7. Fires fuel mercury emissions, University of Michigan study finds
8. Global warming of the future is projected by ancient carbon emissions
9. Increase in carbon dioxide emissions accelerating
10. UGA scientists discover bacterial switch gene that regulates oceans sulfur emissions into the air
11. Study considers auto industry and consumer behavior in reducing greenhouse gas emissions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Isoprene emission from plants volatile answer heat stress

(Date:6/30/2015)... 30, 2015 Genisphere announced ... to help further develop Genisphere,s therapeutics capabilities and portfolio. ... having spent much of the last 25 years in ... Bioscience, and Johnson & Johnson. Tom started his career ... Biotech Corporate Finance. He graduated from Dartmouth College with ...
(Date:6/26/2015)... 26, 2015 ATL Technology, LLC, a top provider ... in single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Jose, Costa Rica ). This acquisition will ... with ATL Technology,s existing facility in Costa ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and manufacturing of surgical instruments in Orthopedics, announced today the acquisition of ... the world's largest provider of surgical instruments to the Spine Industry. The acquisition ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: